Original news and analysis on international IP policy
Key players in the biotechnology industry are leading an effort to obtain global approval processes for generic biological medicines, which experts say could provide cheaper access to costly but widely prescribed and promising treatments.
布鲁塞尔 - 全球公共卫生活跃分子声称，欧盟执意要在一系列自由贸易协议中添加有关医药专利的强硬规定将会妨害发展中国家获得医药。
ابروكسل- إن الجهود التي يبذلها الاتحاد الأوروبي لإدراج أحكام حول براءات المستحضرات الصيدلانية في سلسلة من اتفاقات التجارة الحرة التي يتفاوض حولها قد تشكل تهديدا على إمكانية الحصول على الأدوية في البلدان النامية، على حد قول الناشطين في مجال الصحة العامة على الصعيد العالمي.
BRUXELLES - Selon certains activistes de la santé publique mondiale, les efforts de l’Union européenne (UE) pour intégrer des dispositions sur les brevets pharmaceutiques dans un certain nombre d’accords de libre échange en cours de négociation pourraient mettre en péril l’accès aux médicaments dans les pays en développement.
BRUSELAS- Los esfuerzos de la Unión Europea para introducir disposiciones firmes en materia de patentes farmacéuticas en una serie de acuerdos de libre comercio que está negociando podrían poner en peligro el acceso a los medicamentos en los países en desarrollo, según han afirmado activistas de la salud pública a nivel mundial.
As the United States battles an economic meltdown, items like economic stimulus and home foreclosure relief are taking centre stage. Congress also is still working to confirm President Obama's nominees. But once those items are dealt with, issues such as patent reform and intellectual property enforcement are expected to be hot-button items once again.
French legislators are putting the final touches on controversial legislation that will likely lead to the most governmentally-proactive law intended to curb illegal file sharing among any other European Union member state.
Leading international public health advocates have sent letters to the heads of the World Health Organization and World Trade Organization calling on them to act to prevent possible circumvention of international trade rules for intellectual property rights relating to shipments of legal generic drugs bound for developing countries.
A small group of United States congressional staff and officials from the Obama administration working on intellectual property issues were in Geneva this week to discuss IP policy with representatives of intergovernmental organisations and industry, according to sources.
The effort to tackle digital piracy is likely to remain the most contentious intellectual property issue in Europe this year. It will be joined by debates on copyright term extension, IP provisions in trade agreements, and an ongoing discussion of patent policy in Europe.
BRUSSELS - Efforts by the European Union to insert strong provisions on pharmaceutical patents in a series of free trade agreements it is negotiating could imperil access to medicines in developing countries, global public health activists have alleged.
As part of trade talks being conducted with India, Colombia, Peru and a regional grouping in south-east Asia, EU officials have proposed that drug-makers should benefit from a robust intellectual property regime. National regulatory authorities in the countries concerned would be prevented for lengthy periods from using data provided by a company that holds a drug patent in order to authorise a generic version of that medicine.
Readers may have noticed a few changes to the Intellectual Property Watch website, which we hope will make us easier to use as we bring you the same great content like breaking and in-depth stories and expert views, plus new features like a microblog (the IP Burble), better subscription management, improved search capabilities, a new discussion forum, more podcasts and other products and services.
For those signed up to our RSS feed, you will need to update your feed reader with the following new feed address: http://feeds2.feedburner.com/ip-watch
For personal subscriptions, please always use your email address to login on the new website (your password is unchanged). If any doubt, you can request a new password below the login form.
If you are part of a group subscription, the administrator of your group has received or will receive new instructions.
If you have questions, email us at info@ip-watch.ch.